News &
Notifications

Home 9 Newsroom ( Page 10 )

Newsroom

Here you will find the latest ESG and investor relations news, studies and press releases from cometis AG and our partner PRGN – Public Relations Global Network.
With the capital market panel and the investor relations panel, cometis has been conducting studies on current market events in the areas of capital markets, ESG and investor relations for several years. To this end, cometis surveys experts from the respective departments several times a year on current topics. In this context, cometis evaluates the topics and the concept and is also responsible for conducting the study.

 

Here, you can go directly to the respective years of Investor Relations News:

February 25, 2021 SMT Scharf AG: Revocation of admission to the Regulated Market of the Frankfurt Stock Exchange

February 25, 2021 SMT Scharf AG: Revocation of admission to the Regulated Market of the Frankfurt Stock Exchange

SMT Scharf AG (German Securities Code (WKN) 575198, ISIN DE0005751986) has been informed as part of its downlisting from the Frankfurt Stock Exchange that the exchange has today published its decision to revoke the admission of the shares of SMT Scharf AG to trading on its Regulated Market and in its Prime Standard segment.
ESG: The pressure of NGOs on companies

ESG: The pressure of NGOs on companies

At least since the Fridays for Future demonstrations took place, it seems society is placing increasing importance on the protection of ...
12 February 2021 | Dermapharm Holding SE expects the cooperation with BioNTech SE in vaccine production to make a high double-digit million € contribution to sales in 2021

12 February 2021 | Dermapharm Holding SE expects the cooperation with BioNTech SE in vaccine production to make a high double-digit million € contribution to sales in 2021

Ad hoc news to the archive Dermapharm Holding SE expects the cooperation with BioNTech SE in vaccine production to make a high double-digit ...
February 12, 2021 | Dermapharm Holding SE expands capacity to produce COVID-19 vaccine and plans for vaccine manufacturing to contribute high double-digit million € in sales in 2021

February 12, 2021 | Dermapharm Holding SE expands capacity to produce COVID-19 vaccine and plans for vaccine manufacturing to contribute high double-digit million € in sales in 2021

Corporate news to the archive Dermapharm Holding SE expands capacity to produce COVID-19 vaccine and plans for vaccine manufacturing to ...
KPS OFF TO A SOLID START IN THE NEW FINANCIAL YEAR 2020/2021

KPS OFF TO A SOLID START IN THE NEW FINANCIAL YEAR 2020/2021

KPS continues with robust EBITDA in Q1 2020/2021; Group sales amounted to 36.3 million euros; EBITDA amounting to 5.3 million euros achieved
ESG: The role of ESG for private equity

ESG: The role of ESG for private equity

In its latest study, Finance Magazin asked around 40 investment managers from medium-sized private equity houses about the role ESG plays in ...

CONTACT

Accept Privacy Policy

DIRECTION